LataMed AI Corp. (OTC: LMED) announced that its Chief Executive Officer, Dr. Kevin Rodan, is expected to be recognized by the Ministry of Health with a Certificate of Excellence for his contributions to healthcare innovation, technological development, clinical practice, and healthcare advancement. The award, scheduled to be presented on July 10, 2026, is part of Ministry of Health initiatives aimed at acknowledging healthcare professionals whose work supports innovation, medical technology development, and high standards of patient care.
The recognition underscores the growing importance of healthcare technology, digital infrastructure, and innovation-focused leadership in modernizing healthcare systems throughout Latin America, according to the company. Dr. Rodan's leadership at LataMed AI, a development-stage digital health and artificial intelligence technology company focused on emerging markets, aligns with the region's pressing need for improved healthcare accessibility and coordination.
In a statement, Dr. Rodan said: "I am honored to be recognized in connection with healthcare innovation and excellence. Healthcare systems throughout Latin America continue to face significant accessibility, coordination, and infrastructure challenges, and I believe technology can play an important role in helping address those challenges. This recognition is meaningful not only personally, but also because it reflects the broader importance of innovation, collaboration, and patient-focused healthcare development."
The Certificate of Excellence is expected to be presented during an upcoming Ministry of Health event dedicated to recognizing contributions to healthcare advancement. The company noted that the recognition relates to Dr. Rodan's professional contributions and leadership within the healthcare sector and does not constitute a regulatory approval, endorsement, or certification of any specific product, service, technology, or commercial initiative.
LataMed AI is focused on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled healthcare solutions for emerging markets, with an initial regional focus on Latin America. The company's strategy centers on developing technology platforms to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, insurance accessibility, payment solutions, and data-driven healthcare operations.
This announcement comes as healthcare systems across Latin America grapple with significant challenges in accessibility and infrastructure. The recognition of Dr. Rodan by the Ministry of Health signals a growing emphasis on integrating technology into healthcare delivery. For the industry, this highlights the potential for AI and digital health solutions to address systemic gaps. For patients, it could mean improved access to care and more efficient health systems. The award also positions LataMed AI as a key player in the region's healthcare transformation, though the company remains in the development stage and faces risks typical of emerging technology ventures.
For more information, visit LataMed AI's website or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
